We are analyzing https://link.springer.com/article/10.1186/scrt459.

Title:
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease | Stem Cell Research & Therapy
Description:
We have assessed the utility of autologous mesenchymal stem cell (MSC) peripheral vein infusion as a possible therapeutic modality for patients with end-stage liver diseases. Forty patients with post-hepatitis C virus (HCV) end-stage liver disease were randomized into two groups: Group 1 (GI): 20 patients who received granulocyte colony-stimulating factor (G-CSF) for 5 days followed by autologous MSCs peripheral-vein infusion and group 2 (GII): 20 patients who received regular liver-supportive treatment only (control group). In MSC-infused patients (GI), 54% showed near normalization of liver enzymes and improvement in liver synthetic function. Significant changes were reported in albumin (P = 0.000), bilirubin (P = 0.002), increased international normalized ratio (INR) (P = 0.017), prothrombin concentration (P = 0.029) and alanine transaminase (ALT) levels (P = 0.029), with stabilization of clinical and biochemical status in 13% of cases. None of the patients in GII showed any significant improvement. Hepatic fibrosis was assessed in GI by detection of procollagen IIIC peptide level (PIIICP) and procollagen III N peptide level (PIIINP). The pretreatment values of s-PIIICP and s-PIIINP were 9.4 ± 4.2 and 440 ± 189, respectively, with a decrease to 8.1 ± 2.6 and 388 ± 102, respectively, 3 months after MSC therapy. However, the difference was statistically nonsignificant (P = 0.7). A significant correlation coefficient was reported after 3 months between the s-PIIINP and prothrombin concentration (P = -0.5) and between s-PIIICP and ascites (P = 0.550). First, autologous MSC infusion into a peripheral vein is as effective as the previously reported intrahepatic infusion. Second, MSCs have a supportive role in the treatment of end-stage liver disease, with satisfactory tolerability and beneficial effects on liver synthetic functions and hepatic fibrosis. Third, IV infusion of MSCs after G-CSF mobilization improves s-albumin within the first 2 weeks and prothrombin concentration and alanine Taransaminase after 1 month. According to the data from this current study and those previously reported by our group, we recommend further studies on patients’ infusion with pure CD133 and CD34 followed by IV infusion of in vitro-differentiated MSCs within 1 week and another infusion after 3 months. ClinicalTrials.gov NCT01729221 . Registered 17 November 2012.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

patients, liver, cells, stem, ascites, cell, mscs, infusion, group, article, pubmed, study, google, scholar, months, figure, treatment, cas, autologous, control, hepatic, gcsf, transplantation, bone, authors, disease, marrow, compared, mesenchymal, groups, data, endstage, peripheral, full, factor, clinical, month, differentiation, significant, followup, size, table, massive, original, vein, cairo, mild, moderate, therapy, received,

Topics {✒️}

granulocyte colony-stimulating factor el-kasr al-aini school stromal-derived factor-1-cxcr4 bm-derived stem cells kaser el-aini school bone marrow-derived mscs positive cell-selection kit full size image end-stage liver disease stem cell-treated patients mesenchymal stem cells bm-derived liver repopulation end-stage liver diseases article download pdf anti-collagen formation agent express g-csf receptor hepatic stellate cells portal vein thrombosis child-pugh score progression hepatic stem cells hematopoietic stem cells significant correlation coefficient stellate cell activation simple work-flow chart stem cell separation stem cell isolation 1 ng/ml g-csf peripheral vein infusion peripheral-vein infusion c-met receptor stem cell laboratory full access nonparametric mann-whitney test cd105y versus cd45-pe hepatocyte growth factor child-pugh grade compared liver cell failure stellate cells’ activation stem cells delivery stem cell characterization portal-tract thickening egyptian hcv-positive patients growth-factor receptors hepatic fibrosis markers hepatic oval cells g-csf mobilization mscs-treated patients started therapeutic stem cells related subjects privacy choices/manage cookies

Questions {❓}

Christensen E: Prognostic models including the Child-Pugh, MELD and Mayo risk scores: where are we and where should we go?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
         description:We have assessed the utility of autologous mesenchymal stem cell (MSC) peripheral vein infusion as a possible therapeutic modality for patients with end-stage liver diseases. Forty patients with post-hepatitis C virus (HCV) end-stage liver disease were randomized into two groups: Group 1 (GI): 20 patients who received granulocyte colony-stimulating factor (G-CSF) for 5 days followed by autologous MSCs peripheral-vein infusion and group 2 (GII): 20 patients who received regular liver-supportive treatment only (control group). In MSC-infused patients (GI), 54% showed near normalization of liver enzymes and improvement in liver synthetic function. Significant changes were reported in albumin (P = 0.000), bilirubin (P = 0.002), increased international normalized ratio (INR) (P = 0.017), prothrombin concentration (P = 0.029) and alanine transaminase (ALT) levels (P = 0.029), with stabilization of clinical and biochemical status in 13% of cases. None of the patients in GII showed any significant improvement. Hepatic fibrosis was assessed in GI by detection of procollagen IIIC peptide level (PIIICP) and procollagen III N peptide level (PIIINP). The pretreatment values of s-PIIICP and s-PIIINP were 9.4 ± 4.2 and 440 ± 189, respectively, with a decrease to 8.1 ± 2.6 and 388 ± 102, respectively, 3 months after MSC therapy. However, the difference was statistically nonsignificant (P = 0.7). A significant correlation coefficient was reported after 3 months between the s-PIIINP and prothrombin concentration (P = -0.5) and between s-PIIICP and ascites (P = 0.550). First, autologous MSC infusion into a peripheral vein is as effective as the previously reported intrahepatic infusion. Second, MSCs have a supportive role in the treatment of end-stage liver disease, with satisfactory tolerability and beneficial effects on liver synthetic functions and hepatic fibrosis. Third, IV infusion of MSCs after G-CSF mobilization improves s-albumin within the first 2 weeks and prothrombin concentration and alanine Taransaminase after 1 month. According to the data from this current study and those previously reported by our group, we recommend further studies on patients’ infusion with pure CD133 and CD34 followed by IV infusion of in vitro-differentiated MSCs within 1 week and another infusion after 3 months. ClinicalTrials.gov NCT01729221 . Registered 17 November 2012.
         datePublished:2014-05-28T00:00:00Z
         dateModified:2014-05-28T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/2.0/
         sameAs:https://doi.org/10.1186/scrt459
         keywords:
            International Normalize Ratio
            Massive Ascites
            Stem Cell Infusion
            MSCs Transplantation
            Autologous Mesenchymal Stem Cell
            Stem Cells
            Cell Biology
            Regenerative Medicine/Tissue Engineering
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig8_HTML.jpg
         isPartOf:
            name:Stem Cell Research & Therapy
            issn:
               1757-6512
            volumeNumber:5
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hosny Salama
               affiliation:
                     name:El-Kasr Al-Aini School of Medicine, Cairo University
                     address:
                        name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abdel-Rahman N Zekri
               affiliation:
                     name:Cancer Biology Department, National Cancer Institute, Cairo University
                     address:
                        name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Eman Medhat
               affiliation:
                     name:El-Kasr Al-Aini School of Medicine, Cairo University
                     address:
                        name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shereen A Al Alim
               affiliation:
                     name:El-Kasr Al-Aini School of Medicine, Cairo University
                     address:
                        name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ola S Ahmed
               affiliation:
                     name:Cancer Biology Department, National Cancer Institute, Cairo University
                     address:
                        name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abeer A Bahnassy
               affiliation:
                     name:National Cancer Institute, Cairo University
                     address:
                        name:Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mai M Lotfy
               affiliation:
                     name:Cancer Biology Department, National Cancer Institute, Cairo University
                     address:
                        name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rasha Ahmed
               affiliation:
                     name:El-Kasr Al-Aini School of Medicine, Cairo University
                     address:
                        name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sherief Musa
               affiliation:
                     name:El-Kasr Al-Aini School of Medicine, Cairo University
                     address:
                        name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
      description:We have assessed the utility of autologous mesenchymal stem cell (MSC) peripheral vein infusion as a possible therapeutic modality for patients with end-stage liver diseases. Forty patients with post-hepatitis C virus (HCV) end-stage liver disease were randomized into two groups: Group 1 (GI): 20 patients who received granulocyte colony-stimulating factor (G-CSF) for 5 days followed by autologous MSCs peripheral-vein infusion and group 2 (GII): 20 patients who received regular liver-supportive treatment only (control group). In MSC-infused patients (GI), 54% showed near normalization of liver enzymes and improvement in liver synthetic function. Significant changes were reported in albumin (P = 0.000), bilirubin (P = 0.002), increased international normalized ratio (INR) (P = 0.017), prothrombin concentration (P = 0.029) and alanine transaminase (ALT) levels (P = 0.029), with stabilization of clinical and biochemical status in 13% of cases. None of the patients in GII showed any significant improvement. Hepatic fibrosis was assessed in GI by detection of procollagen IIIC peptide level (PIIICP) and procollagen III N peptide level (PIIINP). The pretreatment values of s-PIIICP and s-PIIINP were 9.4 ± 4.2 and 440 ± 189, respectively, with a decrease to 8.1 ± 2.6 and 388 ± 102, respectively, 3 months after MSC therapy. However, the difference was statistically nonsignificant (P = 0.7). A significant correlation coefficient was reported after 3 months between the s-PIIINP and prothrombin concentration (P = -0.5) and between s-PIIICP and ascites (P = 0.550). First, autologous MSC infusion into a peripheral vein is as effective as the previously reported intrahepatic infusion. Second, MSCs have a supportive role in the treatment of end-stage liver disease, with satisfactory tolerability and beneficial effects on liver synthetic functions and hepatic fibrosis. Third, IV infusion of MSCs after G-CSF mobilization improves s-albumin within the first 2 weeks and prothrombin concentration and alanine Taransaminase after 1 month. According to the data from this current study and those previously reported by our group, we recommend further studies on patients’ infusion with pure CD133 and CD34 followed by IV infusion of in vitro-differentiated MSCs within 1 week and another infusion after 3 months. ClinicalTrials.gov NCT01729221 . Registered 17 November 2012.
      datePublished:2014-05-28T00:00:00Z
      dateModified:2014-05-28T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/2.0/
      sameAs:https://doi.org/10.1186/scrt459
      keywords:
         International Normalize Ratio
         Massive Ascites
         Stem Cell Infusion
         MSCs Transplantation
         Autologous Mesenchymal Stem Cell
         Stem Cells
         Cell Biology
         Regenerative Medicine/Tissue Engineering
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fscrt459/MediaObjects/13287_2013_Article_371_Fig8_HTML.jpg
      isPartOf:
         name:Stem Cell Research & Therapy
         issn:
            1757-6512
         volumeNumber:5
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hosny Salama
            affiliation:
                  name:El-Kasr Al-Aini School of Medicine, Cairo University
                  address:
                     name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abdel-Rahman N Zekri
            affiliation:
                  name:Cancer Biology Department, National Cancer Institute, Cairo University
                  address:
                     name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Eman Medhat
            affiliation:
                  name:El-Kasr Al-Aini School of Medicine, Cairo University
                  address:
                     name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shereen A Al Alim
            affiliation:
                  name:El-Kasr Al-Aini School of Medicine, Cairo University
                  address:
                     name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ola S Ahmed
            affiliation:
                  name:Cancer Biology Department, National Cancer Institute, Cairo University
                  address:
                     name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abeer A Bahnassy
            affiliation:
                  name:National Cancer Institute, Cairo University
                  address:
                     name:Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mai M Lotfy
            affiliation:
                  name:Cancer Biology Department, National Cancer Institute, Cairo University
                  address:
                     name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rasha Ahmed
            affiliation:
                  name:El-Kasr Al-Aini School of Medicine, Cairo University
                  address:
                     name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sherief Musa
            affiliation:
                  name:El-Kasr Al-Aini School of Medicine, Cairo University
                  address:
                     name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Stem Cell Research & Therapy
      issn:
         1757-6512
      volumeNumber:5
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:El-Kasr Al-Aini School of Medicine, Cairo University
      address:
         name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:Cancer Biology Department, National Cancer Institute, Cairo University
      address:
         name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:El-Kasr Al-Aini School of Medicine, Cairo University
      address:
         name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:El-Kasr Al-Aini School of Medicine, Cairo University
      address:
         name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:Cancer Biology Department, National Cancer Institute, Cairo University
      address:
         name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:National Cancer Institute, Cairo University
      address:
         name:Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:Cancer Biology Department, National Cancer Institute, Cairo University
      address:
         name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:El-Kasr Al-Aini School of Medicine, Cairo University
      address:
         name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
         type:PostalAddress
      name:El-Kasr Al-Aini School of Medicine, Cairo University
      address:
         name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hosny Salama
      affiliation:
            name:El-Kasr Al-Aini School of Medicine, Cairo University
            address:
               name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Abdel-Rahman N Zekri
      affiliation:
            name:Cancer Biology Department, National Cancer Institute, Cairo University
            address:
               name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Eman Medhat
      affiliation:
            name:El-Kasr Al-Aini School of Medicine, Cairo University
            address:
               name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Shereen A Al Alim
      affiliation:
            name:El-Kasr Al-Aini School of Medicine, Cairo University
            address:
               name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Ola S Ahmed
      affiliation:
            name:Cancer Biology Department, National Cancer Institute, Cairo University
            address:
               name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Abeer A Bahnassy
      affiliation:
            name:National Cancer Institute, Cairo University
            address:
               name:Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Mai M Lotfy
      affiliation:
            name:Cancer Biology Department, National Cancer Institute, Cairo University
            address:
               name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Rasha Ahmed
      affiliation:
            name:El-Kasr Al-Aini School of Medicine, Cairo University
            address:
               name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Sherief Musa
      affiliation:
            name:El-Kasr Al-Aini School of Medicine, Cairo University
            address:
               name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
      name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
      name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
      name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
      name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
      name:Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt
      name:Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
      name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
      name:Hepatology and Tropical Medicine Department, El-Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt

External Links {🔗}(147)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Normalize.css
Prism.js

4.16s.

LINK . SPRINGER . COM {}